March 5, 2018
Flu Rages as FDA Approval Process Delays New Cure
The release of a new drug that could quickly cure influenza is being delayed by Food & Drug Administration’s (FDA) overly cumbersome approval process.
View past issues as PDFs
Your support of Heartland will allow us to continue to educate others about our work.Give to Heartland